NCT06507748View on ClinicalTrials.gov

A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 28, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions

Neurofibromatosis Type 1

Interventions

DEVICE

AlgometRx Nociometer

Novel objective pain measurement device

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT06507748 - A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1) | Biotech Hunter | Biotech Hunter